Literature DB >> 9887025

Lumped constant for deoxyglucose is decreased when myocardial glucose uptake is enhanced.

K Hashimoto1, T Nishimura, K I Imahashi, H Yamaguchi, M Hori, H Kusuoka.   

Abstract

Quantification of myocardial glucose uptake by positron emission tomography with [18F]fluorodeoxyglucose (FDG) requires the "lumped constant" (LC), which corrects the difference of affinity between glucose and FDG to glucose transporters and phosphorylating system. Since LC was introduced, it has been considered to be constant. However, this has recently been questioned. To elucidate the constancy of LC by other than radioisotope techniques, the accumulation rate of sugar phosphates (d[SP]/dt) was measured in isolated, perfused rat hearts by 31P NMR spectroscopy with 2-deoxyglucose (DG). We postulate alpha as the affinity of DG to transporters and the phosphorylating system relative to that of glucose. Theoretically, alpha is equivalent to LC. We determined alpha by measuring d[SP]/dt at DG concentration ([DG]) = 10, 7, 5, and 3 mmol/l, keeping the total of glucose concentration ([glucose]) and [DG] to 10 mmol/l. When the glucose uptake was enhanced by insulin (10 mU/ml) or stunning, calculated alpha was reduced (insulin stimulated, 0.15; stunning, 0.19) compared with the control (0.59). These results indicate that LC can be evaluated by methods without radiolabeled tracers and is smaller when glucose uptake is augmented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9887025     DOI: 10.1152/ajpheart.1999.276.1.H129

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints.

Authors:  K R Ingram; A K T Wann; C K Angel; P J Coleman; J R Levick
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

2.  Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.

Authors:  Koichi Morita; Chietsugu Katoh; Keiichiro Yoshinaga; Kazuyuki Noriyasu; Megumi Mabuchi; Takahiro Tsukamoto; Hiroyuki Kageyama; Tohru Shiga; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-18       Impact factor: 9.236

Review 3.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

4.  Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.

Authors:  Andrew M Hernandez; Jennifer S Huber; Stephanie T Murphy; Mustafa Janabi; Gengsheng L Zeng; Kathleen M Brennan; James P O'Neil; Youngho Seo; Grant T Gullberg
Journal:  J Nucl Med       Date:  2013-10-03       Impact factor: 10.057

5.  Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo.

Authors:  Min Zhong; Clayton E Alonso; Heinrich Taegtmeyer; Bijoy K Kundu
Journal:  J Nucl Med       Date:  2013-02-20       Impact factor: 10.057

Review 6.  Translation of myocardial metabolic imaging concepts into the clinics.

Authors:  Adil Bashir; Robert J Gropler
Journal:  Cardiol Clin       Date:  2009-05       Impact factor: 2.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.